Krupa Sourirajan None;
Kevin Mendez None;
Georgiy Kozak None;
Gregory Tsougranis None;
Ines Lains None;
Haemin Kang None;
Augustine Bannerman None;
Roshni Bhat None;
Hanna Choi None;
Archana Nigalye None;
Ivana Kim Biophytis, Kodiak Sciences, Code C (Consultant/Contractor);
Demetrios Vavvas Olix Pharma, Valitor, TwentyTwenty, Sumitomo/Sunovion, Cambridge Polymer Group, Code C (Consultant/Contractor), National Eye Institute, NIH, Research to Prevent Blindness, Loefflers Family Foundation, Yeatts Family Foundation, and Alcon Research Institute, Code F (Financial Support), Drusolv Therapeutics, Code O (Owner), Massachusetts Eye and Ear, Code P (Patent), Olix Pharma, Valitor, Code S (non-remunerative);
David Wu Massachusetts Eye and Ear, Code P (Patent);
John Miller Alcon, Allergan, Carl Zeiss, Sunovion, Genentech, and Topcon, Code C (Consultant/Contractor);
Joan Miller Genetech/Roche, Heidelberg Engineering, Sunovion, KalVista Pharmaceuticals, ONL Therapeutics, Code C (Consultant/Contractor), Lowy Medical Research Institute, National Eye Institute, Heidelberg Engineering , Code F (Financial Support), Ciendias Bio, Code I (Personal Financial Interest), Drusolv Therapeutics, ONL Therapeutics, Valeant Pharmaceuticals/Mass. Eye and Ear , Code P (Patent), Valeant Pharmaceuticals/Mass. Eye and Ear, KalVista Pharmaceuticals, Sunovion, Aptinyx, Inc. , ONL Therapeutics, Code R (Recipient), Aptinyx, Inc. , ONL Therapeutics, Code S (non-remunerative);
Deeba Husain Genentech, Allergan, Novartis, Omeicos Therapeutics, Code C (Consultant/Contractor), NIH, National Eye Institute, Lions Vision Gift, Commonwealth Grant, Lions International, Syneos LLC, and the Macular Society, Code F (Financial Support)